Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Autoimmune Disease Diagnosis Global Market Report 2022 Including: 1) By Product: Consumables & Assay Kits; Instruments 2) By Test Type: Routine Laboratory Tests; Autoantibodies Tests; Immunologic Tests; Other Tests 3) By End User: Clinical Laboratories; Hospitals; Other End Users Covering: Thermo Fisher Scientific; Siemens Healthineers; Abbott; Danaher; Bio-Rad Laboratories; Trinity Biotech; HYCOR Biomedical
... focuses on autoimmune disease diagnosis market which is experiencing strong growth. The report gives a guide to the autoimmune disease diagnosis market which will be shaping and changing our lives over the next ten years ... Read More
-
Antibody Therapy Market Size By Type (Monoclonal Antibodies [mAbs] {Oncology, Autoimmune Diseases, Infectious Diseases}, Antibody-drug Conjugates [ADCs]), By End-use (Hospitals, Specialty Centers), Industry Analysis Report, Regional Outlook, Growth Potential, COVID-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Market Share & Forecast, 2022 - 2028 The antibody therapy market is estimated to grow significantly by 2028 owing to the increase in use of monoclonal antibodies (mABs) in COVID-19 patients. Following the onset of ... Read More
-
Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Others), By Packaging Type (Vial, Syringes, and Cartridge), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Lyophilization or freeze drying is the process in which the water content ... Read More
-
Cell Therapy And Gene Therapy Markets
... Information presents the market in segments that provide an overview of disease epidemiology, market estimates and forecasts, and competitive summary of leading providers: Cell and Gene Therapy Market Summary by Product Segment, 2021-2031 ($ millions) ... Read More
-
Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes)
... Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes) The monoclonal antibody market is projected to reach US$ 243.05 billion by 2028 from US$ 111.01 billion in 2021; ... Read More
-
Next-Generation Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Area (Oncology and Autoimmune or Inflammatory) and Technology (Antibody-Drug Conjugates, Bispecific Antibodies, Fc Engineered Antibodies, Antibody Fragments and Antibody-Like Proteins, and Biosimilar Antibody Products
... Biosimilar Antibody Products The global next-generation antibody market is expected to reach US$ 12,050.13 million by 2028 from US$ 5,428.41 million in 2021; it is estimated to grow at a CAGR of 11.9% from 2021 ... Read More
-
Sjogren's Syndrome - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Sjogren's Syndrome Understanding The DelveInsight Sjogren's Syndrome ... Read More
-
Genomics Personalized Health Market By Technology (NGS Platforms, RT-PCR, Microarray, Genetic Analyzers) By Test Type (Oncology Testing, Infectious Disease Testing, Autoimmune Disease Testing, Others) By End-User (Academics & Research Institutes, Diagnostic Centers, Others): Global Industry Perspective, Comprehensive Analysis And Forecast, 2021 – 2030
... Perspective, Comprehensive Analysis And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Genomics Personalized Health Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts ... Read More
-
Generalized Myasthenia Gravis (gMG) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Generalized Myasthenia Gravis ... Read More
-
Warm Autoimmune Hemolytic Anemia (WAIHA)- Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Warm ... Read More
-
Cutaneous Lupus Erythematosus (CLE) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Cutaneous Lupus Erythematosus ... Read More
-
Autoimmune Hepatitis - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Autoimmune Hepatitis Understanding The DelveInsight Autoimmune Hepatitis ... Read More
-
Autoimmune pulmonary alveolar proteinosis (aPAP) - Market Insight, Epidemiology and Market Forecast -2032
... pulmonary alveolar proteinosis (aPAP) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune pulmonary alveolar proteinosis (aPAP) market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Autoimmune Gastritis - Epidemiology Forecast - 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Autoimmune Gastritis Understanding The DelveInsight Autoimmune Gastritis ... Read More
-
Autoimmune pulmonary alveolar proteinosis (aPAP) - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Autoimmune ... Read More
-
Systemic Lupus Erythematosus - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Systemic Lupus Erythematosus Understanding The ... Read More
-
Human Microbiome Market - By Product (Probiotics, Prebiotics, Medical Foods, And Supplements), By Application (Therapeutics And Diagnostics) And By Disease Type (Obesity, Diabetes, Autoimmune Disorder, Metabolic & Gastrointestinal Disorders, And Cancer): Global Industry Perspective, Comprehensive Analysis And Forecast, 2021 – 2030
... Analysis And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Human Microbiome Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. According ... Read More
-
Autoimmune Encephalitis (AE) - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Autoimmune Encephalitis (AE) Understanding The ... Read More
-
Rabies Immunoglobulins - Epidemiology Forecast - 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Rabies Immunoglobulins Understanding The DelveInsight Rabies Immunoglobulins ... Read More
-
Cutaneous Lupus Erythematosus - Market Insight, Epidemiology and Market Forecast -2032
... in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cutaneous Lupus Erythematosus market report provides current treatment practices, emerging drugs, Cutaneous Lupus Erythematosus market share of the individual therapies, ... Read More
-
Global Kinase Inhibitor in Autoimmune Diseases - Epidemiology Forecast - 2032
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: ... Read More
-
Lupus Nephritis - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Lupus Nephritis Understanding The DelveInsight Lupus Nephritis ... Read More
-
Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Guillain-Barre Syndrome (GBS) Understanding The ... Read More
-
Dense Deposit Disease - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Dense Deposit Disease Understanding The ... Read More
-
The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others)
... likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. This ... Read More
Research Assistance
